Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae

Completed · Phase 2/Phase 3

Conditions studied: End Stage Renal Disease, AV Fistula, Kidney Failure

In brief

The SAVE Study will evaluate the safety and efficacy of the Venous Window Needle Guide in achieving access of a deep, un-cannulatable arteriovenous fistula to complete hemodialysis as prescribed.

Key facts

Study ID

NCT01471041

Run by

Vital Access Corp.

People needed

54

Starts

2011-12-01

Expected to finish

2013-06-01

Last updated by the study team

2016-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Deep, uncannulatable, upper extremity arteriovenous fistula
• Minimum arteriovenous fistula flow 400 ml/min
• One year life expectancy

You may not qualify if…

• Non-transposed basilic or brachial vein arteriovenous fistula
• History of peripheral vascular disease
• History of cardiovascular disease
• History of cerebral vascular disease

Where it is running

• Ladenheim Dialysis Access Centers — Fresno, California, United States
• University of Oklahoma - Tulsa — Tulsa, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.